• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

δ阿片样物质激动剂和拮抗剂药效团构象的统一分子模型。

A uniform molecular model of delta opioid agonist and antagonist pharmacophore conformations.

作者信息

Brandt W

机构信息

Institute of Biochemistry, Martin-Luther-University Halle-Wittenberg, Germany.

出版信息

J Comput Aided Mol Des. 1998 Nov;12(6):615-21. doi: 10.1023/a:1008003421291.

DOI:10.1023/a:1008003421291
PMID:9879509
Abstract

On the basis of a model of the pharmacophore conformations of agonist of the delta-opioid receptor the corresponding delta-antagonist conformations were determined by means of force field calculations. The results explain the unusual behavior of several cyclic beta-casomorphin analogues on the molecular level. Thus, for instance, the model helps to understand why Tyr-c[D-Orn-2-Nal-D-Pro-Gly] is a mixed mu-agonist and delta-antagonist. Furthermore, the model is consistent with low energy conformations of other delta-antagonists such as Tyr-Tic-Phe, Tyr-Tic-Phe-Phe, naltrindole and BNTX. The occupation of a special spatial area by bulky groups close to the protonated N-terminus of opioid peptides is assumed to be highly critical for the switch from agonist to antagonist behavior.

摘要

基于δ-阿片受体激动剂药效团构象模型,通过力场计算确定了相应的δ-拮抗剂构象。结果从分子水平解释了几种环β-酪蛋白吗啡类似物的异常行为。例如,该模型有助于理解为什么Tyr-c[D-鸟氨酸-2-萘-D-脯氨酸-甘氨酸]是一种混合μ-激动剂和δ-拮抗剂。此外,该模型与其他δ-拮抗剂如Tyr-Tic-Phe、Tyr-Tic-Phe-Phe、纳曲吲哚和BNTX的低能构象一致。靠近阿片肽质子化N端的大基团占据特殊空间区域被认为对从激动剂行为转变为拮抗剂行为至关重要。

相似文献

1
A uniform molecular model of delta opioid agonist and antagonist pharmacophore conformations.δ阿片样物质激动剂和拮抗剂药效团构象的统一分子模型。
J Comput Aided Mol Des. 1998 Nov;12(6):615-21. doi: 10.1023/a:1008003421291.
2
Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.环β-酪蛋白吗啡类似物3位芳香族氨基酸取代对μ-阿片样物质激动剂/δ-阿片样物质拮抗剂性质的影响。
Int J Pept Protein Res. 1996 Nov;48(5):411-9.
3
The mu- and delta-opioid pharmacophore conformations of cyclic beta-casomorphin analogues indicate docking of the Phe3 residue to different domains of the opioid receptors.环状β-酪蛋白吗啡类似物的μ-和δ-阿片样物质药效团构象表明,苯丙氨酸3残基与阿片样物质受体的不同结构域对接。
J Comput Aided Mol Des. 1996 Jun;10(3):201-12. doi: 10.1007/BF00355043.
4
Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.具有μ激动剂/δ拮抗剂混合特性的环β-酪蛋白吗啡类似物:合成、药理学特征及构象方面
J Med Chem. 1994 Apr 15;37(8):1136-44. doi: 10.1021/jm00034a011.
5
Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assays.通过拓扑偏向、二维核磁共振和生物活性测定确定的CTAP类似物中阿片类芳香药效团的构效关系。
J Med Chem. 2000 Feb 24;43(4):569-80. doi: 10.1021/jm9900218.
6
Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception.δ-阿片样物质配体可逆转阿芬太尼引起的呼吸抑制,但不能逆转其镇痛作用。
J Pharmacol Exp Ther. 1998 Dec;287(3):815-23.
7
Proton NMR conformational analysis of cyclic beta-casomorphin analogues of the type Tyr-cyclo[N omega-D-Orn-Xaa-Yaa-Gly-].酪蛋白衍生的环β-酪蛋白吗啡类似物(Tyr-环[ω-D-鸟氨酸-Xaa-Yaa-甘氨酸-]型)的质子核磁共振构象分析
Arch Pharm (Weinheim). 1996 Mar;329(3):133-42. doi: 10.1002/ardp.19963290305.
8
Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.与H-Tyr-Tic-Phe-OH相关的δ-阿片样物质拮抗剂受体结合构象的各种提议模型的比较分析。
Biopolymers. 1995;37(6):391-400. doi: 10.1002/bip.360370606.
9
Subtleties of structure-agonist versus antagonist relationships of opioid peptides and peptidomimetics.阿片肽和拟肽的结构-激动剂与拮抗剂关系的微妙之处。
J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):573-88. doi: 10.3109/10799899909036673.
10
Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.新型的针对δ和μ阿片受体的不带正电荷的配体。
J Med Chem. 2000 Feb 24;43(4):551-9. doi: 10.1021/jm990461z.

引用本文的文献

1
Synthesis and pharmacological activities of 6-glycine substituted 14-phenylpropoxymorphinans, a novel class of opioids with high opioid receptor affinities and antinociceptive potencies.6-甘氨酸取代的 14-苯丙氧基吗啡烷类化合物的合成及药理活性研究,一类新型阿片类药物,具有高阿片受体亲和力和镇痛效力。
J Med Chem. 2011 Feb 24;54(4):980-8. doi: 10.1021/jm101211p. Epub 2011 Jan 14.
2
Quantitative conformationally sampled pharmacophore for delta opioid ligands: reevaluation of hydrophobic moieties essential for biological activity.δ阿片样物质配体的定量构象采样药效团:对生物活性至关重要的疏水部分的重新评估
J Med Chem. 2007 Apr 19;50(8):1799-809. doi: 10.1021/jm0612463. Epub 2007 Mar 17.

本文引用的文献

1
Novel "restoration of function" mutagenesis strategy to identify amino acids of the delta-opioid receptor involved in ligand binding.
J Biol Chem. 1997 Apr 4;272(14):9260-7. doi: 10.1074/jbc.272.14.9260.
2
The mu- and delta-opioid pharmacophore conformations of cyclic beta-casomorphin analogues indicate docking of the Phe3 residue to different domains of the opioid receptors.环状β-酪蛋白吗啡类似物的μ-和δ-阿片样物质药效团构象表明,苯丙氨酸3残基与阿片样物质受体的不同结构域对接。
J Comput Aided Mol Des. 1996 Jun;10(3):201-12. doi: 10.1007/BF00355043.
3
Involvement of Trp-284, Val-296, and Val-297 of the human delta-opioid receptor in binding of delta-selective ligands.人δ-阿片受体的色氨酸-284、缬氨酸-296和缬氨酸-297在δ-选择性配体结合中的作用。
J Biol Chem. 1996 Aug 2;271(31):18789-96. doi: 10.1074/jbc.271.31.18789.
4
Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.与H-Tyr-Tic-Phe-OH相关的δ-阿片样物质拮抗剂受体结合构象的各种提议模型的比较分析。
Biopolymers. 1995;37(6):391-400. doi: 10.1002/bip.360370606.
5
A selective delta 1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for delta 1 opioid receptor agonists and antagonists.一种源自羟吗啡酮的选择性δ1阿片受体激动剂。δ1阿片受体激动剂和拮抗剂存在不同识别位点的证据。
J Med Chem. 1993 Aug 20;36(17):2572-4. doi: 10.1021/jm00069a017.
6
Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.具有μ激动剂/δ拮抗剂混合特性的环β-酪蛋白吗啡类似物:合成、药理学特征及构象方面
J Med Chem. 1994 Apr 15;37(8):1136-44. doi: 10.1021/jm00034a011.
7
Synthesis of naltrexone-derived delta-opioid antagonists. Role of conformation of the delta address moiety.纳曲酮衍生的δ-阿片受体拮抗剂的合成。δ-作用部分构象的作用。
J Med Chem. 1994 Mar 4;37(5):579-85. doi: 10.1021/jm00031a006.
8
Theoretical conformational analysis of the opioid delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2.阿片δ受体拮抗剂H-Tyr-Tic-Phe-OH和μ受体激动剂H-Tyr-D-Tic-Phe-NH2的理论构象分析
Biopolymers. 1994 Sep;34(9):1213-9. doi: 10.1002/bip.360340909.
9
Structure-activity relationships of dermorphin analogues containing N-substituted amino acids in the 2-position of the peptide sequence.在肽序列2位含有N-取代氨基酸的德莫啡类似物的构效关系。
Int J Pept Protein Res. 1995 Jul;46(1):47-55. doi: 10.1111/j.1399-3011.1995.tb00580.x.
10
Antinociceptive potencies of beta-casomorphin analogs as compared to their affinities towards mu and delta opiate receptor sites in brain and periphery.
Peptides. 1982 Sep-Oct;3(5):793-7. doi: 10.1016/0196-9781(82)90017-1.